Ejection Fraction Decline and Cardiotoxicity Following Anthracycline Chemotherapy: A Risk-Focused Study from an Indonesian Tertiary Care Center
Background. Anthracycline chemotherapy is a cornerstone of cancer treatment but poses a risk of cardiotoxicity, often presenting as cancer therapy–related cardiac dysfunction (CTRCD). Monitoring left ventricular ejection fraction (LVEF) is essential to detect early cardiac impairment and support saf...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Professional Edition Eastern Europe
2025-06-01
|
| Series: | Український журнал серцево-судинної хірургії |
| Subjects: | |
| Online Access: | https://cvs.org.ua/index.php/ujcvs/article/view/734 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|